NOT FOR DISTRIBUTION IN THE UNITED STATES, UNITED KINGDOM, THE EUROPEAN ECONOMIC AREA OR AUSTRALIA
London – International organic healthcare company Rapid Nutrition PLC, London, is pleased to announce the listing of its shares at SIX Swiss Exchange, Zurich, effective 29 March 2017. The shares will be traded in EUR under the symbol “RAP”.
SIX Swiss Exchange is, based on its own assessment, Europe’s leading exchange for life sciences companies, representing about 40 percent of the European market capitalization of listed companies in this segment (https://www.six-swiss- exchange.com/issuers/marketplace/life_sciences_en.html).The exchange offers a wealth of experience in cross-border listings, of particular importance to globally diversified Rapid Nutrition, as well as a capital-rich international investor base and high visibility through dedicated sector indices.
“After extensive research and investigation, we are thrilled to introduce our new Pan-European exchange to investors, partners and consumers across the globe,” said Rapid Nutrition Managing Director Simon St. Ledger. “The SIX Swiss Exchange showcases a high profile among investors and analysts, first-class service and a perfect fit for our science-based organic healthcare products.”
Rapid Nutrition’s listing at SIX Swiss Exchange will permit investors a better stock performance comparison with other renowned global brands and market leaders and offers the potential of a higher valuation of Rapid Nutrition with a stronger opportunity to raise capital for global expansion plans. The listing at SIX Swiss Exchange also ensures that Rapid Nutrition will be traded at what the exchange considers to be the most prominent stock market in the Life Sciences sector in Europe.
“We genuinely appreciate our investors’ support, dedication and patience throughout this process and believe we have found the ideal European exchange to bolster Rapid Nutrition’s profile and success across the globe,” St. Ledger added.
About Rapid Nutrition
Rapid Nutrition is a natural healthcare company focused on the research, development and production of a range of life science products. The company was established based on its weight loss supplement range which is exported worldwide and offers consumers a growing range of health and well-being solutions to meet existing and emerging societal health concerns, as well as a providing a number of wider services to the life sciences industry. For more information, please visit http://rnplc.com
Disclaimer: This communication expressly or implicitly contains certain forward-looking statements concerning Rapid Nutrition PLC and its business. Such statements involve certain known and unknown risks, uncertainties and other factors, which could cause the actual results, financial condition, performance or achievements of the Rapid Nutrition group to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Rapid Nutrition PLC is providing this communication as of this date and does not undertake to update any forward-looking statements contained herein as a result of new information, future events or otherwise.
This media information does not constitute an offer to sell, or a solicitation of an offer to buy, any securities. This information does not constitute an offering prospectus within the meaning of article 652a or article 1156 of the Swiss Code of Obligations or a listing prospectus within the meaning of the listing rules of the SIX Swiss Exchange.
This media information is not being issued in countries where the public dissemination of the information contained herein may be restricted or prohibited by law. In particular, this media information is not being issue in the United States of America and should not be distributed to U.S. persons or publications with a general circulation in the United States. Any non-compliance with such restrictions may result in an infringement of U.S. Securities Laws. In particular, the securities of Rapid Nutrition PLC have not been registered under the U.S. Securities laws and may not be offered, sold or delivered within the United States or to U.S. persons absent the registration under or an applicable exemption from the registration requirements of the U.S. Securities laws.
This information is for distribution in the United Kingdom only to: persons who (i) are outside the United Kingdom; (ii) are investment professionals falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (Order); (iii) are persons falling within Article 48(2) of the Order (certified high net worth individuals); (iv) are persons falling within Article 49(2) of the Order (high net worth companies, unincorporated associations, etc.); (v) are persons falling within article 50(1) of the Order (sophisticated investors); (vi) are persons falling within article 50A(1) of the Order (self-certified sophisticated investors); (vii) are persons falling within article 51 of the Order (associations of high net worth or sophisticated investors); or (viii) are persons to whom it may otherwise lawfully be communicated (all such persons together being Relevant Persons). This media information is only available to Relevant Persons and persons other than Relevant Persons must not act or rely on it.
This media information may not be provided in Australia other than to select investors ("Exempt Investors") who are able to demonstrate that they (a) fall within one or more of the categories of investors under section 708 of the Australian Corporations Act to whom an offer may be made without disclosure under Part 6D.2 of the Australian Corporations Act and (b) are "wholesale clients" for the purpose of section 761G of the Australian Corporations Act.